Reuters logo
BRIEF-Gilead announces findings from new preclinical study evaluating novel class of HIV Capsid inhibitors
February 13, 2017 / 11:55 PM / 10 months ago

BRIEF-Gilead announces findings from new preclinical study evaluating novel class of HIV Capsid inhibitors

Feb 13 (Reuters) - Gilead Sciences Inc :

* Gilead announces findings from new preclinical study evaluating novel class of HIV Capsid inhibitors

* Gilead Sciences - to evaluate selected development candidate in IND-enabling toxicology studies and begin phase 1 clinical trials in 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below